Register for the meeting now
285638
Vicious circle of perceived stigma, enacted stigma and depressive symptoms among children affected by HIV/AIDS: A cross-lagged model
Methods: This study explores the longitudinal reciprocal effects of depressive symptoms and stigma, specifically enacted stigma and perceived stigma, among children affected by HIV/AIDS aged 6 to 12. Longitudinal data were collected from 272 children orphaned by AIDS and 249 children of HIV-positive parents in rural China. Cross-lagged panel analysis was conducted in the study.
Results: Results showed that the autoregressive effects were stable for depressive symptoms, perceived stigma and enacted stigma suggesting the substantially stable individual differences over time. The cross-lagged effects indicated a vicious circle among the three variables in an order of enacted stigma->depressive symptom->perceived stigma->enacted stigma. The possibility of employing equal constraints on cross-lagged paths suggested that the cross-lagged effects were repeatable over time.
Conclusion: The dynamic interplay of enacted stigma, perceived stigma and depressive symptoms suggest the need of a multilevel intervention in stigma reduction programming to promote mental health of children affected by HIV/AIDS.
Learning Objectives:
Identify a vicious circle among stigma and depressive symptoms by cross-lagged analyses
Describe the predicting pattern in an order of enacted stigma->depressive symptoms->perceived stigma->enacted stigma
Demonstrate the need to consider the interplay of various components of stigma in mental health promotion
Keywords: HIV/AIDS, Child and Adolescent Mental Health
Qualified on the content I am responsible for because: I am the project coordinator of a federally funded grant focusing on resilience-based intervention among children affected by HIV/AIDS. My research interest includes psychological resilience among children affected by HIV/AIDS and disclosure of HIV infection to family members.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.